Table 4.
Multivariate analyses of overall survival (separate for clinical and for pathological stage)
| Cox regression model with clinical stage | p-value | HR (95% CI) |
|---|---|---|
| Age | ||
| < 65 | 1 | |
| ≥ 65 | 0.003 | 1.58 (1.17 – 2.14) |
| Gender | ||
| Male | 1 | |
| Female | 0.006 | 0.63 (0.46 – 0.88) |
| Clinical TNM stage | 0.092* | |
| I | 1 | |
| II | 0.078 | 1.36 (0.97 – 1.91) |
| IIIA | 0.068 | 1.46 (0.97 – 2.18) |
| Cox regression model with pathological stage | p-value | HR (95% CI) |
| Age | ||
| < 65 | 1 | |
| ≥ 65 | 0.001 | 1.68 (1.24 – 2.28) |
| Gender | ||
| Male | 1 | |
| Female | 0.004 | 0.62 (0.45 – 0.86) |
| Pathological TNM stage | 0.003* | |
| I | 1 | |
| II | 0.076 | 1.37 (0.97 – 1.93) |
| IIIA | 0.001 | 1.95 (1.32 – 2.88) |
*
for the whole variable